| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Catalent, Inc. | Group President, Biologics | Common Stock | 0 | $0 | $59.70 | 18 Dec 2024 | Direct |
| Catalent, Inc. | Group President, Biologics | Option to purchase Common Stock | 0 | 18 Dec 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017024137787-mcerlane-david-2024-12-18 | Catalent, Inc. | 18 Dec 2024 | 4 | $0 | 4 | Group President, Biologics | 18 Dec 2024, 14:07 |
| /report/000159678324000089-mcerlane-david-2024-09-26 | Catalent, Inc. | 26 Sep 2024 | 1 | -$119,580 | 4 | Group President, Biologics | 27 Sep 2024, 12:01 |
| /report/000159678324000060-mcerlane-david-2024-07-26 | Catalent, Inc. | 26 Jul 2024 | 1 | $0 | 4 | Group President, Biologics | 30 Jul 2024, 17:23 |
| /report/000159678323000168-mcerlane-david-2023-10-25 | Catalent, Inc. | 25 Oct 2023 | 0 | $0 | 3 | Group President, Biologics | 02 Nov 2023, 21:17 |